SCHEMBL4167396

SCHEMBL4167396

CNC1CCN(c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
LMNA P02545 2/20 0.56
ALOX12 P18054 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
HTT P42858 3/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
ADRB1 P08588 1/20 0.53
NOTUM Q6P988 1/20 0.50
NPY5R Q15761 1/20 0.49
SLC6A2 P23975 4/20 0.48
SLC6A4 P31645 4/20 0.48
SLC6A3 Q01959 4/20 0.48
CYP2D6 P10635 3/20 0.48
CYP2C19 P33261 2/20 0.48
KCNH2 Q12809 2/20 0.48
DPP4 P27487 1/20 0.47
RAB9A P51151 1/20 0.46
HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4185135 0.98 MAPT (0.54) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL25453136 0.83 HRH4 (0.42) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL2056318 0.81 ADRB1 (0.58) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL785834 0.81 KMT2A (0.50) MAPTMEN1KMT2AADRB1NOTUM
SCHEMBL2094853 0.77 ADRB1 (0.58) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL4169509 0.77 MAPT (0.61) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL23484656 0.77 ADRB1 (0.58) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL6694923 0.77 NOTUM (0.58) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
Hydrochloric Acid SCHEMBL4170680 0.76 MAPT (0.59) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL22728527 0.75 NOTUM (0.52) MAPTSMN1; SMN2LMNAALOX12L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124663-A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors NEUROSEARCH A/S (DK) 2009-05-14 US claimed
EP-1896415-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2008-03-12 EP claimed
WO-2006131524-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2006-12-14 WO claimed
US-20090124663-A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors NEUROSEARCH A/S (DK) 2009-05-14 US disclosed
EP-1896415-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2008-03-12 EP disclosed
WO-2006131524-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124663-A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors SLC18A2, SLC6A2, SLC18A3 MAPT 423/4885SMN1; SMN2 1786/4885LMNA 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.